| INTRODUC TI ON
Asthma and allergy are major public health issues worldwide.
1 As immune and lung development occur largely in utero and during early childhood, developmental programming by pre-and post-natal changing lifestyle and environmental influences acting during this critical period of life is a plausible pathway for respiratory diseases and allergy upsurge over the past few decades. [2] [3] [4] [5] Globally, it is estimated that a billion people may suffer from vitamin D deficiency or insufficiency, 6 including pregnant women who are especially at high risk. 7 Vitamin D status, which is assessed by circulating 25(OH)D levels, is easily modified by sun exposure or diet and therefore makes it an attractive target biomarker for monitoring and prevention. Given the presence of vitamin D receptors on immune cells and the airways, 8 and its multiple effects on the developing lung and immune system, immunomodulation, and regulation of inflammation, [9] [10] [11] [12] vitamin D has gained much interest in recent years as a key modifiable risk factor of asthma and allergy in childhood.
To date, two randomized controlled trials (RCTs) have examined the impact of vitamin D supplementation during pregnancy in relation to wheezing and asthma in the offspring showing inconclusive results. 13 wheeze in the offspring through age 3 years. 13 Another RCT assessed whether supplementation with 4400 IU/d of vitamin D, as compared with 400 IU/d, at 10 to 18 weeks of gestation among pregnant women at high risk of having children with asthma modifies the risk in the offspring. Authors found a non-significant 6.1% decreased incidence of asthma and recurrent wheezing by age 3 years. 14 Few previous meta-analyses have examined the association between prenatal vitamin D status with offspring's risk of asthma and related conditions. [15] [16] [17] A first systematic review meta-analyzing from 3 to 4 studies found that lower maternal vitamin D blood level during pregnancy was associated with an increased risk of eczema in the offspring, but no association was found for asthma or wheeze. 15 A second larger meta-analysis on twelve prospective studies suggested a U-shaped relationship between maternal 25(OH)D levels and risk of asthma. 16 Recently, a meta-analysis of birth cohort studies found increased in utero exposure to 25(OH)D to be inversely associated with the risk of asthma and wheeze during childhood, although no significant association was found for respiratory tract infections (RTIs). 17 No systematic review has examined the role of prenatal vitamin D status on offspring's lung function and allergic manifestations such as allergic sensitization and allergic rhinitis.
Hence, we have conducted a systematic review and randomeffects meta-analysis to reveal the existing evidence from observational studies on the relationship between prenatal vitamin D status-measured as circulating 25(OH)D levels in pregnancy or at birth-and respiratory and allergic conditions during childhood, including RTIs, wheeze, asthma, atopic eczema, allergic rhinitis, allergic sensitization, and lung function.
| ME THODS

| Search strategy of studies
Meta-analyses of study-level observational data were undertaken and reported according to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines. 18 The literature search was carried out by two independent reviewers (R.M.P.G. and E.M.) by the MEDLINE (National Library of Medicine) and Scopus engine searches (see Appendix S1 for further details). Last search was conducted in May 2017 and yielded 240 and 307 records from PubMed and Scopus, respectively. Identification and first screening of the articles were performed using the information available in the title and the abstract. After the first selection, both reviewers read through the articles to decide whether they were eligible or not.
Doubts regarding the inclusion or exclusion of studies were resolved by discussion between the two independent researchers, and if no agreement was reached then a third researcher helped to decide.
| Study eligibility criteria
The selection criteria were (i) article written in English; (ii) original research article based on an epidemiologic study performed in human individuals (abstracts, case reports, ecological studies, comments and laboratory-based studies were excluded); (iii) available information on circulating concentration of vitamin D in maternal blood during pregnancy or in cord blood at birth as exposure; (iv) inclusion of children from birth to 18 years as study subjects; (v) inclusion of physician diagnosis or parental report of offspring's respiratory and allergic conditions as outcomes, including RTIs, wheeze, asthma, atopic eczema, allergic rhinitis, allergic sensitization, or lung function; (vi) available data on the relevant risk estimates including odds ratio (OR), relative risk (RR), hazard ratio (HR) and the corresponding 95% confidence intervals (CIs), or beta coefficient estimates and the corresponding 95% CIs for studies on lung function testing.
| Data extraction and quality assessment
For each eligible record included, the following information was ex- * RR/(1-RR * P 0 )], where P 0 indicates the incidence of the outcome of interest in the non-exposed/reference group. 19 For lung function, the beta coefficient for forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC) z-scores were extracted. If some studies reported the results at different follow-up time points, we chose the available data at the longest time point to avoid overrepresentation bias. However, the effect sizes are shown in supplementary tables summarizing the original study results to provide information regarding whether the effect differed depending on the age of the children. When several estimates were reported within the same study, the most adjusted model was used for the pooled analysis. Moreover, when in the same study, vitamin D levels were measured in both maternal and cord blood, both estimates were included in the pooled analysis. Quality of studies was assessed by the two independent reviewers using the criteria defined by the nine-star Newcastle-Ottawa Scale. 20 birth cohorts and one case-control study, from 16 different countries (latitude ranging from 55ºN to 31ºS) (Table S1 ). With regard to the study region, 16 studies were conducted in Europe, 8 in Asia, 6 in North America, and 4 in Australia. Table S1 summarizes the information on prenatal vitamin D exposure assessment and offspring's health outcomes. One study was classified as low quality, 22 were evaluated as moderate quality, and 11 were evaluated as high quality (Table S2) . 
| Data synthesis and statistical analysis
| RE SULTS
| RTIs
Fourteen single studies assessed the association of prenatal 25(OH)
D levels with the occurrence of RTIs in the offspring from birth to Stratified analyses showed stronger associations when analyzing data from studies with 25(OH)D levels measured at birth (Table 1) . 
| Wheeze
| Asthma
| Lung function performance
Seven studies reported the association between prenatal 25(OH)D circulating levels with offspring's lung function from age 6 months to 8 years. 
| Atopic eczema
Twelve studies investigated cord blood levels or maternal blood levels in pregnancy of circulating 25(OH)D in relation to offspring's risk of atopic eczema or dermatitis from age 1 to 9 years. 23, 29, [36] [37] [38] [39] [40] 45, 47, 48, 50, 52 The combined results comparing the highest with the lowest category 25(OH)D levels revealed a pooled OR = 1.02 (95% CI 0.89, 1.16; P = .791), (Figure 4) . No heterogeneity (I 2 = 0.0%, P = .125) or publication bias (P = .176, Egger test) was detected. In stratified analysis, a stronger inverse relationship was found when analyzing data from studies based on doctor diagnosis of eczema (n = 2) ( Table 1) . Results obtained from the meta-regression analyses showed no modification of the effects by geographical localization (ie, latitude), except for atopic eczema: the higher the latitude, the stronger the association (P = .002) (Table S10 ). Influence analysis did not reveal any study that substantially affected the pooled results (Table S11 ).
| Allergic rhinitis
| D ISCUSS I ON
In this systematic review and meta-analysis, we found that prenatal ex- 
| S TRENG TH S AND LIMITATI ON S
The main strength of this meta-analysis is that we investigated a wide range of respiratory and allergic conditions in childhood, some of them not previously examined, such as allergic sensitization, allergic rhinitis, and lung function performance, which adds value to this meta-analysis. Moreover, we obtained de novo data from some primary studies, 31, 33, 41, 44 17 Differences in the number of analyzed studies could explain these discrepancies between meta-analyses. In addition, the findings of the present study on asthma and wheeze are in line with inconclusive results from of two recent randomized trials. 13, 14 Inconclusive results for wheeze and asthma probably reflect inconsistencies across studies in the definition, diagnosis and assessment of theses outcomes in childhood, especially at early ages, as well as the complexity of the pathogenesis of these respiratory conditions.
A previous meta-analysis based on 3 studies revealed a protective effect of maternal vitamin D against childhood eczema 15 ; however, our results based on available data from 12 studies did not confirm previous findings. These discrepancies are probably due to the different number of studies analyzed. To the best of our knowledge, this is the first meta-analysis on the association between prenatal vitamin D and allergic sensitization, allergic rhinitis, and lung function performance.
| P OSS IB LE E XPL ANATI ON S OF FINDING S
Our findings on the protective effect of prenatal vitamin D exposure on the occurrence of RTIs during preschool age, especially within the first 6 months of age, are in accordance with the summarized evidence derived from randomized controlled trials on vitamin D supplementation to prevent acute respiratory tract infections. 57 Diverse mechanisms by which vitamin D may induce protection against respiratory pathogens have been described. 25-hydroxyvitamin D supports induction of antimicrobial peptides such as cathelicidin and defensin in response to both bacterial and viral stimuli, including the respiratory syncytial virus. 58, 59 Vitamin D also influences human antimicrobial activity by acting on lymphocytes, neutrophils, macrophages, and respiratory epithelial cells through vitamin D receptors. 60 Moreover, adequate vitamin D levels would contribute to reduce inflammation and favor a milder disease in persons infected with the respiratory syncytial virus. 61 Vitamin D has also effects on lung development and function.
Experimental and human studies have revealed vitamin D to play a key role in lung maturation by modulating type II alveolar cell differentiation and by stimulating surfactant synthesis and release. [62] [63] [64] [65] Antenatal vitamin D deficiency impairs airway and alveolar development and limits lung function in mice. 9 Moreover, vitamin D deficiency may provoke proliferation and hypertrophy of smooth muscle, contributing to airway remodeling and increased airway smooth muscle mass. 
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